Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostim-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostim

Published:2011-09 Issue:5 Volume:16 Page:274-277
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Michel Marc¹,te Boekhorst Peter A W²,Janssens Ann³,Pabinger-Fasching Ingrid⁴,Sanz Miguel A⁵,Nie Kun⁶,Kreuzbauer Georg⁷

Affiliation:

1. Service de Médecine InterneCHU Henri Mondor AP-HP, Université Paris, Créteil, France

2. Department of HematologyErasmus Medical Center, Rotterdam, The Netherlands

3. Department of HematologyUniversity Hospitals Leuven, Belgium

4. Department of Internal MedicineMedical University of Vienna, Austria

5. Department of HaematologyUniversity Hospital La Fe, Valencia, Spain

6. Amgen (Europe) GmbHZug, Switzerland

7. Amgen Inc.Thousand Oaks, CA, USA

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1179/102453311X13025568942005

Reference14 articles.

1. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

2. International consensus report on the investigation and management of primary immune thrombocytopenia

3. Current Options for the Treatment of Idiopathic Thrombocytopenic Purpura

4. Novel Thrombopoietic Agents

5. The epidemiology of glucocorticoid-associated adverse events

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus;Annals of Hematology;2023-02-24

2. Clinical overview and practical considerations for optimizing romiplostim therapy in patients with immune thrombocytopenia;Blood Reviews;2021-09

3. Corticosteroid overuse in adults with immune thrombocytopenia: Cause for concern;Research and Practice in Thrombosis and Haemostasis;2021-08

4. EFFICACY AND SAFETY OF THROMBOPOIETIN RECEPTOR AGONISTS IN MODERN TREATMENT OF IMMUNE THROMBOCYTOPENIA;FARMACIA;2021-04-20

5. Treatment patterns in adults with immune thrombocytopenia before, during and after use of thrombopoietin receptor agonists: a longitudinal prescription database study from Germany;Hematology;2021-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3